Gyre Therapeutics, Inc.

General ticker "GYRE" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $797.6M (TTM average)

Gyre Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -8.2%.

Estimated limits based on current volatility of 2.7%: low 7.93$, high 8.37$

Factors to consider:

  • Total employees count: 5 as of 2024
  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [7.04$, 16.65$]
  • 2025-12-31 to 2026-12-31 estimated range: [5.28$, 12.79$]

Financial Metrics affecting the GYRE estimates:

  • Positive: with PPE of 148.5 at the end of fiscal year the price was very low
  • Negative: Operating cash flow per share per price, % of -0.36 <= 0.33
  • Positive: 7.86 < Operating profit margin, % of 15.28
  • Negative: negative Industry operating cash flow (median)
  • Positive: 41.86 < Shareholder equity ratio, % of 50.49 <= 63.39
  • Negative: -0.15 < Industry inventory ratio change (median), % of 0
  • Positive: Return on assets ratio (scaled to [-100,100]) of 12.49 > 6.04

Similar symbols

Short-term GYRE quotes

Long-term GYRE plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $102.29MM $113.45MM $105.76MM
Operating Expenses $93.09MM $180.68MM $89.59MM
Operating Income $9.20MM $-67.23MM $16.16MM
Non-Operating Income $0.21MM $-9.73MM $7.05MM
R&D Expense $16.69MM $13.78MM $12.02MM
Income(Loss) $9.41MM $-76.97MM $23.22MM
Taxes $5.10MM $8.52MM $5.32MM
Profit(Loss)* $2.30MM $-92.93MM $12.09MM
Stockholders Equity $42.52MM $-15.83MM $63.32MM
Inventory $6.12MM $4.28MM $6.34MM
Assets $84.75MM $116.54MM $125.41MM
Operating Cash Flow $10.68MM $25.89MM $-3.64MM
Capital expenditure $5.00MM $8.59MM $3.13MM
Investing Cash Flow $-13.81MM $-19.76MM $-19.88MM
Financing Cash Flow $0.00MM $2.50MM $2.10MM
Earnings Per Share** $0.03 $-1.41 $0.14

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.